Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cells and their effects on the biocompatibility, in vivo.
The stability of biomedical polymers in physiological environments is crucial for the normal operation of devices, as well as determining their effect on the tissue response. Degradation is an important factor in polymer biocompatibility, since the environment of the human body can be aggressive to polymers. Most implanted polymers suffer degradation to some extent, and the kinetics and mechanisms of the processes can be affected significantly by various biologically active species, especially enzymes, lipids, peroxides, free radicals and phagocytic cells. The degradation of poly(caprolactone) and poly(DL-lactic acid) under controlled in vivo conditions was studied using a poly(methyl methacrylate) chamber designed to control the exposure of polymers to physiological environments. In particular they may be designed to allow access of extracellular exudate only or access to cells as well as the fluid. The chambers, sealed with filters of pore size either 0.45 micron (impervious to cells) or 3.0 microns (allowing cells to enter the chamber), were implanted subcutaneously into experimental animals for 10, 20 and 30 wk periods. Degradation and molecular interactions of the polymers were characterized by gel permeation chromatography and scanning electron microscopy. The extracellular exudate formed within the implanted chamber is active in promoting the degradation of some biomedical polymers. Inflammatory cells are involved in the biodegradation of implanted polymers by releasing biologically active species such as free radicals into the area surrounding the implant. The data have demonstrated that the hydroxyl radical is likely to be one of the main causes of polymer degradation.
Ali
S A
SA
Department of Clinical Engineering, Royal Liverpool University Hospital, UK.
Doherty
P J
PJ
Williams
D F
DF
D000818:Animals; D001672:Biocompatible Materials / Q000009:adverse effects / Q000737:chemistry; D001673:Biodegradation, Environmental; D004347:Drug Interactions; D005110:Extracellular Space / Q000187:drug effects*; D005122:Exudates and Transudates; D007773:Lactates / Q000009:adverse effects / Q000737:chemistry; D019344:Lactic Acid; D008855:Microscopy, Electron, Scanning; D008970:Molecular Weight; D011091:Polyesters / Q000009:adverse effects / Q000737:chemistry; D011108:Polymers / Q000009:adverse effects / Q000737:chemistry; D019736:Prostheses and Implants; D051381:Rats
D001672:Biocompatible Materials; D007773:Lactates; D011091:Polyesters; D011108:Polymers; C016240:polycaprolactone; D019344:Lactic Acid; C033616:poly(lactide)